General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Esperion(SIGNIFICANT), Amgen(MODEST), Medtronic(MODEST), Edwards(MODEST), Sanofi-Aventis(MODEST), Novo Nordisk Inc.(SIGNIFICANT), CSL Behring (MODEST), Eli Lilly and Company(SIGNIFICANT), jazz pharmaceuticals(SIGNIFICANT), Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Novartis Corporation(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Epirium Bio(MODEST) RESEARCH/RESEARCH GRANTS: Dexcom(MODEST), argenx(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Merck & Co., Inc.(MODEST)

View Full Disclosure